Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
39,000,391
-
Share change
-
+130,477
-
Total reported value
-
$50,727,151
-
Put/Call ratio
-
61%
-
Price per share
-
$1.30
-
Number of holders
-
82
-
Value change
-
+$146,680
-
Number of buys
-
35
-
Number of sells
-
20
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q4 2016
As of 31 Dec 2016,
TRANSENTERIX INC - COM NEW (TRXC) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,000,391 shares.
The largest 10 holders included
Aisling Capital LLC, SV Life Sciences Advisers, LLC, JPMORGAN CHASE & CO, StepStone Group LP, VANGUARD GROUP INC, BlackRock Fund Advisors, MASTERS CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., AQR CAPITAL MANAGEMENT LLC, and INTERNATIONAL BIOTECHNOLOGY TRUST PLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.